![]() |
|
|


*
Laboratory for Oxidation Biology, Genetics and Aging Unit, Departments of Psychiatry and
Neurology, Harvard Medical School, Massachusetts General Hospital, Charleston, MA 02129
3To whom correspondence should be addressed.
Alzheimers disease (AD) is characterized by amyloid deposits within
the neocortical parenchyma and the cerebrovasculature. The main
component of these predominantly extracellular collections, Aß, which
is normally a soluble component of all biological fluids, is cleaved
out of a ubiquitously expressed parent protein, the amyloid protein
precursor (APP), one of the type 1 integral membrane glycoproteins.
Considerable evidence has indicated that there is zinc dyshomeostasis
and abnormal cellular zinc mobilization in AD. We have characterized
both APP and Aß as copper/zinc metalloproteins. Zinc, copper and iron
have recently been reported to be concentrated to 0.5 to 1 mmol/L in
amyloid plaque. In vitro, rapid Aß aggregation is mediated by Zn(II),
promoted by the
-helical structure of Aß, and is reversible with
chelation. In addition, Aß produces hydrogen peroxide in a
Cu(II)/Fe(III)-dependent manner, and the hydrogen peroxide formation is
quenched by Zn(II). Moreover, zinc preserves the nontoxic properties of
Aß. Although the zinc-binding proteins apolipoprotein E
4
allele and
2-macroglobulin have been characterized as
two genetic risk factors for AD, zinc exposure as a risk factor for AD
has not been rigorously studied. Based on our findings, we envisage
that zinc may serve twin roles by both initiating amyloid deposition
and then being involved in mechanisms attempting to quench oxidative
stress and neurotoxicity derived from the amyloid mass. Hence, it
remains debatable whether zinc supplementation is beneficial or
deleterious for AD until additional studies clarify the issue.
KEY WORDS: Alzheimers disease amyloid precursor protein Aß amyloid zinc homeostasis
This article has been cited by other articles:
![]() |
J. Hidalgo, M. Penkowa, C. Espejo, E. M. Martinez-Caceres, J. Carrasco, A. Quintana, A. Molinero, S. Florit, M. Giralt, and A. Ortega-Aznar Expression of Metallothionein-I, -II, and -III in Alzheimer Disease and Animal Models of Neuroinflammation. Experimental Biology and Medicine, October 1, 2006; 231(9): 1450 - 1458. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Frederickson, S. W. Suh, D. Silva, C. J. Frederickson, and R. B. Thompson Importance of Zinc in the Central Nervous System: The Zinc-Containing Neuron J. Nutr., May 1, 2000; 130(5): 1471S - 1483. [Abstract] [Full Text] |
||||
![]() |
Y. Yoshiike, K. Tanemura, O. Murayama, T. Akagi, M. Murayama, S. Sato, X. Sun, N. Tanaka, and A. Takashima New Insights on How Metals Disrupt Amyloid beta -Aggregation and Their Effects on Amyloid-beta Cytotoxicity J. Biol. Chem., August 17, 2001; 276(34): 32293 - 32299. [Abstract] [Full Text] [PDF] |
||||